IMT SCHOOL FOR ADVANCED STUDIES LUCCA Even before public announcements of the first cases of COVID-19 in Europe were made, at the end of January 2020, signals that something strange was happening were already circulating on social media. A new study of researchers at IMT School for Advanced Studies Lucca, published in Scientific Reports, has identified tracks of increasing...
Tag: <span>COVID-19</span>
Post
NSAIDs might exacerbate or suppress COVID-19 depending on timing, mouse study suggests
AMERICAN SOCIETY FOR MICROBIOLOGY Washington, DC – January 22, 2021 – New research shows that non-steroidal anti-inflammatory drugs (NSAIDs) reduced both antibody and inflammatory responses to SARS-CoV-2 infection in mice. The study appears this week in the Journal of Virology, a publication of the American Society for Microbiology. The research is important because “NSAIDs are arguably the most commonly used...
Post
Researchers ID potential target for anti-viral drugs to battle COVID-19
by Ohio University Credit: Ohio University While the world awaits broad distribution of COVID-19 vaccines, researchers at Ohio University just published highly significant and timely results in the search for another way to stop the virus—by disrupting its RNA and its ability to reproduce. Dr. Jennifer Hines, a professor in the Department of Chemistry and Biochemistry, along with...
Post
COVID-19 (coronavirus): Long-term effects
COVID-19 symptoms can sometimes persist for months. The virus can damage the lungs, heart and brain, which increases the risk of long-term health problems. By Mayo Clinic Staff Most people who have coronavirus disease 2019 (COVID-19) recover completely within a few weeks. But some people — even those who had mild versions of the disease...
Post
Rush researchers demonstrate success with new therapy for COVID-19
RUSH UNIVERSITY MEDICAL CENTER A new therapy developed by researchers at Rush University Medical Center is showing success as a way to prevent COVID-19 symptoms in mice. In a study published in the Journal of Neuroimmune Pharmacology, mouse models with COVID-19 showed positive results when a small peptide was introduced nasally. The peptide proved effective in reducing fever, protecting...
Post
COVID-19 SPIT TESTS WORK JUST AS WELL AS NOSE SWABS
JANUARY 19TH, 2021,POSTED BY FABIENNE LANDRY-MCGILL “Previous studies on the performance of saliva tests showed mixed results, but most of them compared saliva tests to the standard nasal swab test, as if it was a perfect test,” says Guillaume Butler-Laporte. “Interestingly, there are no perfect tests for COVID-19.” (Credit: Omar Marques/Getty Images) Two new studies...
Post
The immune system mounts a lasting defense after recovery from COVID-19
As the number of people who have fought off SARS-CoV-2 climbs ever higher, a critical question has grown in importance: How long will their immunity to the novel coronavirus last? A new Rockefeller study offers an encouraging answer, suggesting that those who recover from COVID-19 are protected against the virus for at least six months,...
Post
A clinical trial provides encouraging results on ivermectin for reducing mild COVID-19
by Barcelona Institute for Global Health SAINT Research team. Credit: ISGlobal/Clínica Universidad de Navarra. A small pilot study suggests that early administration of ivermectin can reduce viral loads and symptom duration in patients with mild COVID-19, which in turn could help reduce viral transmission. The study, which is part of the SAINT project and has been led by...
Post
Smart watches can detect symptoms of COVID-19 before wearer knows they are infected
by Bob Yirka , Medical Xpress Credit: CC0 Public Domain A team of researchers at the Icahn School of Medicine at Mount Sinai has found evidence that suggests smart watches can detect COVID-19 symptoms before a person has become aware that they are infected. On their website, the team at Mount Sinai describes testing 297...
Post
Coronavirus Disease 2019 (COVID-19) Clinical Presentation
Updated: Jan 09, 2021 Author: David J Cennimo, MD, FAAP, FACP, AAHIVS; Chief Editor: Michael Stuart Bronze, MD Clinical Progression A retrospective, single-center study from Shanghai evaluated clinical progression of COVID-19 in 249 patients. The interval from symptom onset to hospitalization averaged 4 days (range, 2-7 days) among symptomatic patients. The vast majority (94.3%) of patients developed fever....